Dupixent Lawsuit & Settlement in New Orleans, LA

Recent studies show a link between dupilumab, the active ingredient in Dupixent, and an increased risk of cutaneous T-cell lymphoma (CTCL) skin cancer. This is a serious risk that the drug fails to provide a warning for. Those affected by the negligence of DuPont manufacturers may be able to file a claim. Understanding a potential Dupixent lawsuit & settlement in New Orleans, LA, can help you assess the ways you can financially recover from a claim.

What Damages Can a Dupixent Settlement Get?

When you have a valid case against Dupixent manufacturers, you could recover compensatory damages for any financial or personal losses you suffered. Compensatory damages include both economic and non-economic damages. Economic damages are financial losses with set values, while non-economic damages are intangible and non-financial losses like mental, emotional, and psychological damage. Compensatory damages include:

• Medical costs, including the current bills you have and the future costs for long-term treatment
• Lost income, during which you were unable to work because of medical treatment and physical recovery
• Reduced earning capacity, when your condition has affected your ability to do your job or be gainfully employed
• Pain and suffering, including chronic physical pain, emotional trauma, disfigurement, and disability
• Reduced quality of life, including loss of consortium or lost enjoyment of life

Because each individual’s life is uniquely affected by their condition, these damages can range significantly. Each claim is unique, depending on the specific costs of your condition and how it impacts your daily life, so there is no way to know your damages based on averages. Instead, it is important to discuss your case with an attorney who can help calculate your damages.

An attorney has resources like medical professionals and other expert opinions to help accurately assess the immediate and future costs your condition may have on your life. This information helps you maximize the financial recovery you can get in a Dupixent claim.

How Does Injury Severity Affect Damages?

One of the primary factors in determining the value of a possible settlement is the severity of your CTCL or T-cell lymphoma (TCL). These are rare types of skin cancer that develop in the white blood cells. Early symptoms include rashes, scaly skin patches, discolored skin, swollen lymph nodes, skin pain, fevers, weight loss, and fatigue.

When CTCL is diagnosed early, it is more likely that the progression of the condition can be treated until remission. Because this has fewer costs and less impact on life expectancy, the settlement amount will be lower.

Medical expenses can be costly, and they can impact your life, but to a lesser extent. If CTCL or TCL is moderate, requires more treatment, and has a greater relapse risk, the costs are likely to be higher. Moderate conditions impact the rest of your life more significantly.

When CTCL is diagnosed at the advanced state, it requires aggressive medical treatment and has a higher risk of fatality. The costs of this are much more significant, as there are high-cost medical treatments required, potential long-term hospitalization, and a potential permanent impact on the rest of your life, family, finances, and employment.

What Else Impacts Settlement Value?

Settlement or verdict values are affected by more than the severity of your condition. Other factors need to be considered, such as:

• Legal representation. When you have a skilled attorney by your side to file a Dupixent claim, you are likely to recover a higher settlement or verdict. Your legal representation can assess your claim, help you understand potential outcomes, and fight for your rights in negotiations or in court. Without an attorney, you are more likely to accept a settlement that fails to address your losses.
• Documentation and evidence. Clear evidence of your medical diagnosis and treatment, of your use of Dupixent, and other documentation is important for a strong case. A stronger case makes it easier to secure a full and fair settlement or prove your case in court.
• Manufacturer conduct. Current cases allege that Dupixent manufacturers were aware of the cancer risks of the drug and failed to disclose them anyway. If the evidence shows that this is true, or that the safety tests and data were misrepresented to cover the risks, it can impact the case. The manufacturers may have to pay additional damages.

These and many other factors, like whether the case goes to trial, or your age and earning capacity, can influence outcomes. An attorney can help give a more accurate estimate.

FAQs

What Is the Dupixent Controversy?

The Dupixent controversy is about an alleged link between the use of the anti-inflammatory drug dupilumab and certain types of skin cancer. There is an increased risk of developing cutaneous T-cell lymphoma (CTCL) and the use of Dupixent. Claims being filed over this risk allege that the manufacturers of this drug were aware of these risks and failed to disclose them and warn patients of these potential side effects.

Is Dupixent Linked to Lymphoma?

There is a potential link between Dupixent and a specific type of lymphoma. Research has seen an increased risk from 300% to 450% of developing CTCL skin cancer with the use of dupilumab. This is the active ingredient in Dupixent. The increased risk shown in research remained high even after the use of dupilumab stopped. Use of the injectable drug may also worsen existing skin cancer.

Is There a Case Against Dupixent?

There are cases against the Dupixent manufacturers for the failure to warn of the side effects of their drug. Instead of being combined in one class action case, Dupixent cases might be a mass tort case. If you believe you have the grounds for a claim due to a CTCL or T-cell lymphoma (TCL) diagnosis after multiple shots of Dupixent, you should hire a Dupixent lawsuit lawyer to understand your options for financial recovery.

Is There a Black Box Warning for Dupixent?

There is not currently a black box warning or boxed warning for Dupixent. A boxed warning is the highest level of warning that the Food and Drug Administration (FDA) can put on a medication, for when medical studies suggest a substantial risk of severe, preventable, or fatal effects. The FDA approved the drug in 2017, and some of the main studies were published in 2024 and 2025. The warnings could be changed in the future.

Hire a Dupixent Lawsuit Lawyer in New Orleans

If you believe you have a case, contact Murphy Law Firm today.

About The Author

Peyton Murphy

Peyton Murphy, is the founder of Murphy Law Firm, LLC, based in Baton Rouge, Louisiana, specializing in personal injury law. Peyton obtained his law degree from the prestigious Tulane School of Law in 1991 and has been licensed to practice law in Louisiana since 1993. With over 28 years of experience, Peyton is dedicated to representing injured victims and actively contributing to his community. Education: Obtained his law degree from Tulane School of Law in 1991. Professional Associations: Member of the Louisiana State Bar and active in the Baton Rouge Bar Association and the Louisiana Association for Justice. Experience: Founder of Murphy Law Firm, LLC, with extensive experience in personal injury law and licensed in multiple federal courts and the U.S. Supreme Court.

View all posts by Peyton Murphy →